Enanta Pharmaceuticals | ENTA - Marktkapitalisierung

Aktienkurs
14.11
Täglich Wechseln
0.16 1.15%
Monatlich
-0.42%
Jährlich
200.85%
Q2 Prognose
13.72




Marktkapitalisierung Veränderung Datum
AbbVie USD 403.83B 5.2B 2025-12
Amgen USD 176.25B 24.32B 2025-12
Anika Therapeutics USD 139M 3M 2025-12
Arrowhead Research USD 9.02B 4.25B 2025-12
AstraZeneca USD 288.15B 55.08B 2025-12
BioCryst Pharmaceuticals USD 1.66B 64M 2025-12
Biogen USD 25.82B 5.28B 2025-12
Bristol-Myers Squibb USD 109.81B 18.01B 2025-12
Enanta Pharmaceuticals USD 122M 98M 2024-12
Gilead Sciences USD 152.28B 14.55B 2025-12
GlaxoSmithKline GBP 74.36B 10.31B 2025-12
Halozyme Therapeutics USD 7.91B 664M 2025-12
Heron Therapeutics USD 238M 7M 2025-12
Incyte USD 19.39B 2.83B 2025-12
Insmed USD 37.12B 6.68B 2025-12
Ionis Pharmaceuticals USD 12.81B 2.39B 2025-12
J&J USD 500.24B 67.44B 2025-12
Karyopharm Therapeutics USD 652M 517M 2026-04
Merck USD 261.26B 51.62B 2025-12
Neurocrine Biosciences USD 14.14B 218M 2025-12
Novartis USD 292.21B 26.55B 2025-12
Novavax USD 1.09B 316M 2025-12
Pfizer USD 141.57B 6.48B 2025-12
PTC Therapeutics USD 6.1B 1.22B 2025-12
Roche Holding CHF 266.34B 55.46B 2025-12
Sarepta Therapeutics USD 2.26B 238M 2025-12
Vertex Pharmaceuticals USD 115.03B 14.61B 2025-12